Clincosm LogoSign in Get a demo

Gastric Adenocarcinoma

Showing 76 - 100 of 167
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Squamous Cell of Head and Neck, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in United

Terminated
  • Carcinoma, Squamous Cell of Head and Neck
  • +3 more
  • Coral Gables, Florida
  • +4 more
Mar 1, 2022

Gastric Adenocarcinoma, Metastatic Adenocarcinoma of the Gastroesophageal Junction Trial in Germany (Ramucirumab, TAS 102)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Metastatic Adenocarcinoma of the Gastroesophageal Junction
  • Frankfurt, Germany
  • +4 more
Mar 2, 2022

Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (CT041 autologous CAR T-cell

Recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • CT041 autologous CAR T-cell injection
  • Physician's Choice（Paclitaxel or Irinotecan or Apatinib or Anti-PD-1 antibody）
  • Hefei, Anhui, China
  • +9 more
Feb 13, 2022

Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),

Recruiting
  • Melanoma
  • +7 more
  • Nivolumab or Pembrolizumab (dependent upon approved indication)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 10, 2022

Gastric Tumor, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Dresden, Heidelberg (Biopsy)

Active, not recruiting
  • Gastric Neoplasm
  • +4 more
  • Biopsy
  • Dresden, Germany
  • +1 more
Feb 22, 2022

Treatment of Gastric Adenocarcinoma With Huachansu

Active, not recruiting
  • Gastric Adenocarcinoma
    • Hefei, China
      The First Affiliated Hospital of Anhui Medical University
    Feb 18, 2022

    Gastric Adenocarcinoma Trial in Houston (procedure, drug, other)

    Not yet recruiting
    • Gastric Adenocarcinoma
    • Gastrectomy
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 3, 2022

    Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)

    Recruiting
    • Carcinoma
    • +18 more
    • PEN-866 Sodium
    • +3 more
    • Springdale, Arkansas
    • +15 more
    Feb 16, 2022

    Gastric Adenocarcinoma Trial in Guangzhou (Surufatinib+Sintilimab)

    Not yet recruiting
    • Gastric Adenocarcinoma
    • Guangzhou, Guangdong, China
      Cancer center of SunYat-sen University
    Feb 9, 2022

    Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer Trial in Worldwide (SL-279252)

    Recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • +12 more
    • Nashville, Tennessee
    • +4 more
    Feb 3, 2022

    Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in Netherlands (Capecitabine, Oxaliplatin, Retifanlimab)

    Recruiting
    • Gastric Adenocarcinoma
    • Esophageal Adenocarcinoma
    • Amsterdam, Netherlands
    • +7 more
    Jan 31, 2022

    Gastric Adenocarcinoma Trial in Beijing (Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1)

    Recruiting
    • Gastric Adenocarcinoma
    • Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Jan 27, 2022

    Gastric Adenocarcinoma Trial in France, Spain (HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) with oxaliplatin, Curative

    Active, not recruiting
    • Gastric Adenocarcinoma
    • HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) with oxaliplatin
    • Curative gastrectomy
    • Amiens, France
    • +32 more
    Jan 26, 2022

    Pancreatic Ductal Adenocarcinoma, Colorectal Adenocarcinoma, Gastric Adenocarcinoma Trial in Philadelphia (Adenovirus

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +37 more
    • Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Nov 2, 2021

    Gastric Adenocarcinoma, Esophagogastric Junction Adenocarcinoma, Esophagus Adenocarcinoma Trial in Fuzhou (XBI-302 + Nivolumab)

    Withdrawn
    • Gastric Adenocarcinoma
    • +2 more
    • XBI-302 + Nivolumab
    • Fuzhou, Fujian, China
      Fujian Cancer Hospital
    Oct 19, 2021

    Gastrectomy Outcomes in Elderly Patients

    Not yet recruiting
    • Gastrectomy
    • +3 more
    • Gastrectomy
    • Istanbul, Turkey
      Marmara University Pendik Training and Research Hospital
    Oct 14, 2021

    Esophageal Tumors, Adenocarcinoma of the Gastroesophageal Junction, Gastroesophageal Cancer Trial in United States (DKN-01,

    Completed
    • Esophageal Neoplasms
    • +4 more
    • Los Angeles, California
    • +9 more
    Sep 9, 2021

    Solid Tumor, Triple-negative Breast Cancer, Gastric Adenocarcinoma Trial in Houston, Chuo-Ku (LY3435151, Pembrolizumab)

    Terminated
    Has Results
    • Solid Tumor
    • +8 more
    • Houston, Texas
    • +1 more
    Aug 4, 2021

    Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))

    Completed
    Has Results
    • Gastric Adenocarcinoma
    • +15 more
    • Sacituzumab Govitecan-hziy (SG)
    • Aurora, Colorado
    • +11 more
    Aug 10, 2021

    Gastric Adenocarcinoma, Gastric Cancer Trial in France (Durvalumab, Tremelimumab, FOLFIRI Protocol)

    Active, not recruiting
    • Gastric Adenocarcinoma
    • Gastric Cancer
    • Abbeville, France
    • +34 more
    Jun 17, 2021

    Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in Chicago (Pembrolizumab

    Recruiting
    • Gastroesophageal Junction Adenocarcinoma
    • +2 more
    • Pembrolizumab Injection
    • Chicago, Illinois
      University Of Chicago Medicine Comprehensive Cancer Center
    Jun 7, 2021

    Gastric Adenocarcinoma, Esophageal Adenocarcinoma, Metastasis Trial in United States (Oxaliplatin, Leucovorin, 5 fluorouracil)

    Active, not recruiting
    • Gastric Adenocarcinoma
    • +3 more
    • Duarte, California
    • +6 more
    May 10, 2021

    Gastric Adenocarcinoma Trial in Seoul (TS-1 + cisplatin, radiation)

    Recruiting
    • Gastric Adenocarcinoma
    • TS-1 + cisplatin
    • radiation
    • Seoul, Korea, Republic of
      Severance Hospital, Yonsei University Health System
    Apr 21, 2021

    Gastric Adenocarcinoma, Metastatic Gastric Cancer, Metastatic Adenocarcinoma Trial in France (Atezolizumab + Ipatasertib,

    Recruiting
    • Gastric Adenocarcinoma
    • +3 more
    • Atezolizumab + Ipatasertib
    • Atezolizumab + Bevacizumab
    • Dijon, France
    • +8 more
    Mar 26, 2021

    Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Gastric

    Completed
    • Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction
    • +5 more
    • S-1 de-escalation
    • Chemotherapy by Investigator's choice
    • Heidelberg, Baden-Württemberg, Germany
      NCT-Med. Onkologie
    Mar 25, 2021